{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:59:15Z","timestamp":1793447955318,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:00:00Z","timestamp":1263513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infantile spasms represent a serious epileptic syndrome that occurs in the early infantile age. ACTH and Vigabatrin are actively investigated drugs in its treatment. This study describes the comparison of their efficacy in a large series of patients with infantile spasms from Pakistan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All patients with infantile spasms who presented to Aga Khan University Hospital, Karachi, Pakistan from January, 2006 to April, 2008 were included in this study. Inclusion criteria were clinical symptoms of infantile spasms, hypsarrythmia or modified hyparrythmia on electroencephalography, at least six months of follow-up period and receipt of any of the two drugs mentioned above. The type of drug distribution was random according to the availability, cost and ease of administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty six cases fulfilled the inclusion criteria. 62.5% were males. Mean age at onset of seizures was 5 \u00b1 1.4 months. Fifty two (92.8%) patients demonstrated hypsarrythmia on electroencephalography. 64.3% cases were identified as symptomatic while 19.6% were cryptogenic and 16.1% were idiopathic. Eighteen patients received ACTH while 38 patients received Vigabatrin as first line therapy. Initial response to first line therapy was similar (50% for ACTH and 55.3% for Vigabatrin). Overall, the symptomatic and idiopathic groups responded better to Vigabatrin. The relapse rate was higher for ACTH as compared to Vigabatrin (55.5% vs. 33.3%) when considering the first line therapy. Four patients evolved to Lennox-Gastaut variant; all of these patients had initially received Vigabatrin and then ACTH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Vigabatrin and ACTH showed no significant difference in the initial treatment of infantile spasms. However, patients receiving ACTH were 1.2 times more likely to relapse as compared to the patients receiving Vigabatrin when considering monotherapy. We suggest that Vigabatrin should be the initial drug of choice in patients presenting with infantile spasms. However, larger studies from developing countries are required to validate the therapeutic trends observed in this study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1471-2431-10-1","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T14:16:09Z","timestamp":1263564969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical profile and treatment of infantile spasms using vigabatrin and ACTH - a developing country perspective"],"prefix":"10.1186","volume":"10","author":[{"given":"Shahnaz","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamshad","family":"Gulab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Ishaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taimur","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,15]]},"reference":[{"key":"313_CR1","unstructured":"NINDS Infantile Spasms Information Page: National Institute of Neurological Disorders and Stroke. [http:\/\/www.ninds.nih.gov\/disorders\/infantilespasms\/infantilespasms.htm]"},{"key":"313_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/adc.69.5.614","volume":"69","author":"RE Appleton","year":"1993","unstructured":"Appleton RE: Infantile spasms. Arch Dis Child. 1993, 69: 614-8. 10.1136\/adc.69.5.614.","journal-title":"Arch Dis Child"},{"key":"313_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1535-7511.2006.00100.x","volume":"6","author":"WD Shields","year":"2006","unstructured":"Shields WD: Infantile Spasms: Little Seizures, Big Consequences. Epilepsy Curr. 2006, 6: 63-9. 10.1111\/j.1535-7511.2006.00100.x.","journal-title":"Epilepsy Curr"},{"key":"313_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1535-7511.2005.00047.x","volume":"5","author":"E Ben-Menachem","year":"2005","unstructured":"Ben-Menachem E: Infantile spasms and epilepsy currents. Epilepsy Curr. 2005, 5: 157-8. 10.1111\/j.1535-7511.2005.00047.x.","journal-title":"Epilepsy Curr"},{"key":"313_CR5","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1542\/peds.2005-1867","volume":"117","author":"JL Bonkowsky","year":"2006","unstructured":"Bonkowsky JL, Filloux FM, Byington CL: Herpes Simplex Virus Central Nervous System Relapse During Treatment of Infantile Spasms With Corticotropin. Pediatrics. 2006, 117: e1045-8. 10.1542\/peds.2005-1867.","journal-title":"Pediatrics"},{"key":"313_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.seizure.2005.08.009","volume":"14","author":"M Azam","year":"2005","unstructured":"Azam M, Bhatti N, Krishin J: Use of ACTH and prednisolone in infantile spasms: experience from a developing country. Seizure. 2005, 14: 552-6. 10.1016\/j.seizure.2005.08.009.","journal-title":"Seizure"},{"key":"313_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-244X-7-57","volume":"7","author":"Ather M Taqui","year":"2007","unstructured":"Taqui Ather, Itrat Ahmed, Qidwai Waris, Qadri Zeeshan: Depression in the elderly: Does family system play a role? A cross-sectional study. BMC Psychiatry. 2007, 7: 57-10.1186\/1471-244X-7-57.","journal-title":"BMC Psychiatry"},{"key":"313_CR8","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.0013-9580.2004.02404.x","volume":"45","author":"AL Lux","year":"2004","unstructured":"Lux AL, Osborne JP: A Proposal for Case Definitions and Outcome Measures in Studies of Infantile Spasms and West Syndrome: Consensus Statement of the West Delphi Group. . Epilepsia. 2004, 45: 1416-1428. 10.1111\/j.0013-9580.2004.02404.x.","journal-title":". Epilepsia"},{"key":"313_CR9","doi-asserted-by":"crossref","unstructured":"Hancock EC, Osborne JP, Edwards SW: Treatment of infantile spasms. Cochrane Database Syst Rev. 2008, CD001770-4","DOI":"10.1002\/14651858.CD001770.pub2"},{"key":"313_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1528-1157.1983.tb04874.x","volume":"24","author":"CT Lonbroso","year":"1983","unstructured":"Lonbroso CT: A prospective study on infantile spasms: clinical and therapeutic correlations. Epilepsia. 1983, 24: 135-58. 10.1111\/j.1528-1157.1983.tb04874.x.","journal-title":"Epilepsia"},{"key":"313_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0387-7604(01)00265-0","volume":"23","author":"YS Hwang","year":"2001","unstructured":"Hwang YS: National survey on West syndrome in Korea. Brain Dev. 2001, 23: 584-95. 10.1016\/S0387-7604(01)00265-0.","journal-title":"Brain Dev"},{"key":"313_CR12","unstructured":"Saving Newborn Lives. The state of the world's newborn: a report from saving newborn lives. Washington DC, Save the children. 2001, 1-44."},{"key":"313_CR13","first-page":"341","volume":"15","author":"J Parkash","year":"2005","unstructured":"Parkash J, Das N: Pattern of admissions to neonatal unit. J Coll Physicians Surg Pak. 2005, 15: 341-4.","journal-title":"J Coll Physicians Surg Pak"},{"key":"313_CR14","first-page":"231","volume":"7","author":"ZA Bhutta","year":"1997","unstructured":"Bhutta ZA: Priorities in newborn care and development of clinical neonatology in Pakistan: Where to now?. J Coll Physicians Surg Pak. 1997, 7: 231-4.","journal-title":"J Coll Physicians Surg Pak"},{"key":"313_CR15","first-page":"428","volume":"18","author":"TK Butt","year":"2008","unstructured":"Butt TK, Farooqui R, Khan MA: Risk Factors for Hypoxic Ischemic Encephalopathy in Children. J Coll Physicians Surg Pak. 2008, 18: 428-432.","journal-title":"J Coll Physicians Surg Pak"},{"key":"313_CR16","volume-title":"State of world's children report 2007. Women and children: the double dividend of gender equality","author":"UNICEF","year":"2006","unstructured":"UNICEF: State of world's children report 2007. Women and children: the double dividend of gender equality. 2006, New York: UNICEF"},{"key":"313_CR17","first-page":"67","volume":"19","author":"R Majeed","year":"2007","unstructured":"Majeed R, Memon Y, Majeed F, Shaikh NP, Rajar UD: Risk factors of birth asphyxia. JAyub Med Coll Abbottabad. 2007, 19: 67-71.","journal-title":"JAyub Med Coll Abbottabad"},{"key":"313_CR18","first-page":"553","volume":"52","author":"S Ibrahim","year":"2002","unstructured":"Ibrahim S, Parkash J: Birth asphyxia--analysis of 235 cases. J Pak Med Assoc. 2002, 52: 553-6.","journal-title":"J Pak Med Assoc"},{"key":"313_CR19","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1016\/S0140-6736(05)71048-5","volume":"365","author":"JE Lawn","year":"2005","unstructured":"Lawn JE, Cousens S, Zupan J: 4 million neonatal deaths: When? Where? Why?. Lancet. 2005, 365: 4891-900. 10.1016\/S0140-6736(05)71048-5.","journal-title":"Lancet"},{"key":"313_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/S0140-6736(05)71882-1","volume":"365","author":"J Martines","year":"2005","unstructured":"Martines J, Paul V, Bhutta ZA, Koblinsky M, Saucat A, Walker N, Bahl R, Fogstad H, Costello A: Neonatal survival: a call for action. Lancet. 2005, 365: 1189-97. 10.1016\/S0140-6736(05)71882-1.","journal-title":"Lancet"},{"key":"313_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cppeds.2005.11.002","volume":"36","author":"B Azra Haider","year":"2006","unstructured":"Azra Haider B, Bhutta ZA: Birth asphyxia in developing countries: current status and public health implications. Curr Probl Pediatr Adolesc Health Care. 2006, 36: 178-88. 10.1016\/j.cppeds.2005.11.002.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"313_CR22","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","volume":"364","author":"AL Lux","year":"2004","unstructured":"Lux AL, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP: The United Kingdom Infantile Spasms Study comparing Vigabatrin with Prednisolone or Tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet. 2004, 364: 1773-78. 10.1016\/S0140-6736(04)17400-X.","journal-title":"Lancet"},{"key":"313_CR23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","volume":"38","author":"F Vigevano","year":"1997","unstructured":"Vigevano F, Cilio MR: Vigabatrin versus ACTH as first line treatment for Infantile Spasms: a randomized, prospective study. Epilepsia. 1997, 38: 1270-1274. 10.1111\/j.1528-1157.1997.tb00063.x.","journal-title":"Epilepsia"},{"key":"313_CR24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/j.1528-1157.1999.tb02049.x","volume":"40","author":"E Appleton","year":"1999","unstructured":"Appleton E, Peters ACB, Mumford JP, Shaw DE: Randomised, placebo controlled study of vigabatrin as first line treatment of infantile spasms. Epilepsia. 1999, 40: 1627-1633. 10.1111\/j.1528-1157.1999.tb02049.x.","journal-title":"Epilepsia"},{"key":"313_CR25","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","volume":"62","author":"MT Mackay","year":"2004","unstructured":"Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Snead OC: Practice parameter: medical treatment of infantile spasms. Report of American Academy of Neurology and the Child Neurology Society. Neurology. 2004, 62: 1668-81.","journal-title":"Neurology"},{"key":"313_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1212\/WNL.52.8.1691","volume":"52","author":"P Cossette","year":"1999","unstructured":"Cossette P, Rivello JJ, Carmant L: ACTH versus Vigabatrin therapy in infantile spasms: a retrospective study. Neurology. 1999, 52: 1691-1694.","journal-title":"Neurology"},{"key":"313_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0887-8994(93)90024-7","volume":"9","author":"PK Sher","year":"1993","unstructured":"Sher PK, Sheikh MR: Therapeutic efficacy of ACTH in symptomatic infantile spasms with hypsarrythmia. Pediatr Neurol. 1993, 9: 451-456. 10.1016\/0887-8994(93)90024-7.","journal-title":"Pediatr Neurol"},{"key":"313_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.97.3.375","volume":"97","author":"TZ Baram","year":"1996","unstructured":"Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ: High dose Corticotropin (ACTH) Versus Prednisone for Infantile Spasms: A Prospective Randomized, Blinded Study. Pediatrics. 1996, 97: 375-379.","journal-title":"Pediatrics"},{"key":"313_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0022-3476(83)80606-4","volume":"103","author":"RA Hrachovy","year":"1983","unstructured":"Hrachovy RA, Frost JD, Kellaway P, Zion TE: Double-blind study of ACTH versus prednisone therapy in infantile spasms. J Pediatr. 1983, 103: 641-64. 10.1016\/S0022-3476(83)80606-4.","journal-title":"J Pediatr"},{"key":"313_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1212\/WNL.39.8.1027","volume":"39","author":"OC Snead","year":"1989","unstructured":"Snead OC, Benton JW Jr, Hosey LC, Swann JW, Spink D, Martin D, Rej R: Treatment of infantile spasms with high dose ACTH: Efficacy and plasma levels of ACTH and prednisone. Neurology. 1989, 39: 1027-1031.","journal-title":"Neurology"},{"key":"313_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.seizure.2008.09.006","volume":"18","author":"G Karvelas","year":"2009","unstructured":"Karvelas G, Lortie A, Scantlebury MH, Duy PT, Cossette P, Carmant L: A retrospective study on aetiology based outcome of infantile spasms. Seizure. 2009, 18: 197-201. 10.1016\/j.seizure.2008.09.006.","journal-title":"Seizure"},{"key":"313_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/adc.55.9.664","volume":"55","author":"R Riikonen","year":"1980","unstructured":"Riikonen R, Donner M: ACTH therapy in infantile spasms: side effects. Arch Dis Child. 1980, 55: 664-72. 10.1136\/adc.55.9.664.","journal-title":"Arch Dis Child"},{"key":"313_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/adc.85.6.469","volume":"85","author":"R Koul","year":"2001","unstructured":"Koul R, Chacko A, Ganesh A, Bulusu S, Al Riyami K: Vigabatrin associated retinal dysfunction in children with epilepsy. Arch Dis Child. 2001, 85: 469-73. 10.1136\/adc.85.6.469.","journal-title":"Arch Dis Child"},{"key":"313_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S0387-7604(01)00286-8","volume":"23","author":"R Koul","year":"2001","unstructured":"Koul R, Chacko A, Cherian E: West syndrome: a university hospital based study from Oman. Brain Dev. 2001, 23: 586-92. 10.1016\/S0387-7604(01)00286-8.","journal-title":"Brain Dev"},{"key":"313_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2165\/00023210-200115030-00005","volume":"15","author":"R K\u00e4lvi\u00e4inen","year":"2001","unstructured":"K\u00e4lvi\u00e4inen R, Nousiainen I: Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs. 2001, 15: 217-30. 10.2165\/00023210-200115030-00005.","journal-title":"CNS Drugs"},{"key":"313_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1746-160X-4-9","volume":"4","author":"T Abu Saleh","year":"2008","unstructured":"Abu Saleh T, Stephen L: Lennox gestaut syndrome, review of the literature and a case report. Head Face Med. 2008, 4: 9-10.1186\/1746-160X-4-9.","journal-title":"Head Face Med"},{"key":"313_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1528-1157.1999.tb00705.x","volume":"40","author":"H Rantala","year":"1999","unstructured":"Rantala H, Putkonen T: Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia. 1999, 40: 286-9. 10.1111\/j.1528-1157.1999.tb00705.x.","journal-title":"Epilepsia"},{"key":"313_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/00004691-200311000-00005","volume":"20","author":"ON Markand","year":"2003","unstructured":"Markand ON: Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol. 2003, 20: 426-41. 10.1097\/00004691-200311000-00005.","journal-title":"J Clin Neurophysiol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-10-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-10-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T12:06:49Z","timestamp":1685362009000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-10-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,15]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-10-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1555973.1047072","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,15]]},"assertion":[{"value":"27 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}